Prospects and problems of gene therapy: an update

Bibliography

• KAY MA, MANNO CS, RAGNI MV et al.: Evidence for gene transfer and expression of Factor IX in haemophilia B patients treated with an AAV vector. Nat. Genet. (2000) 3:257–261.
   Google Scholar
• ••Promising results obtained in gene therapytrial.
   Google Scholar
• CAVAZZANA-CALVO M, HACEIN-BEY S, DE SAINT BASILE G et al.: Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science (2000) 288:669–672.
   PubMed Web of Science ®Google Scholar
• ••Promising results obtained in gene therapytrial.
   Google Scholar
• KHURI FR, NEMUNAITIS J, GANLY I et al.: A controlled trial of intratumoral ONYX-015, a selectively replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nat. Med. (2000) 6: 879–885.
   Google Scholar
• ••Promising results obtained in gene therapytrial.
   Google Scholar
• HOLLON T: Researchers and regulators reflect on first gene therapy death. Nat. Med. (2000) 6:6.
   PubMed Web of Science ®Google Scholar
• WANG B, LI J, MAO X: Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in MDX mouse model. Proc. Natl Acad. Sci. USA (2000) 97:13714–13719.
   PubMed Web of Science ®Google Scholar
• GOUZE E, GHIVIZZANI SC, ROBBINS PD, EVANS CH: Gene therapy for rheumatoid arthritis. Curr. Rheumatol Rep. (2001) 3:79–85.
   PubMedGoogle Scholar
• LEWIN AS, HAUSWIRTH WW: Ribozyme gene therapy: applications for molecular medicine. Trends Md. Med. (2001) 7: 221–228.
   Google Scholar
• TAGALAKIS AD, GRAHAM IR, RIDDELL DR, DICKSON JG, OWEN JS: Gene correction of the apolipoprotein (Apo) E2 phenotype to wild-type ApoE3 by in situ chimeraplasty. J. Biol. Chem. (2001) 276:13226–13230.
   PubMed Web of Science ®Google Scholar
• •Successful application of chimeraplasty technology in gene repair.
   Google Scholar
• REEVES L, CORNETTA K: Clinical retroviral vector production: step filtration using clinically approved filters improves titers. Gene Ther. (2000) 7:1993–1998.
   PubMed Web of Science ®Google Scholar
• BURNS JC, FRIEDMANN T, DRIEVER W, BURRASCANO M, YEE JK: Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl Acad. Sci. USA (1993) 90:8033–8037.
   PubMed Web of Science ®Google Scholar
• SOMIA NV, MIYOSHI H, SCHMITT MJ, VERMA IM: Retroviral vector targeting to human immunodeficiency virus Type 1-infected cells by receptor pseudotyping. J. Vird. (2000) 74:4420–4424.
   PubMed Web of Science ®Google Scholar
• KURIYAMA S, SAKAMOTO T, KIKUKAWA M et al.: Expression of a retrovirally transduced gene under control of an internal housekeeping gene promoter does not persist due to methylation and is restored partially by 5-azacytidine treatment. Gene Ther. (1998) 5: 1299–1305.
   Google Scholar
• LORINCZ MC, SCHUBELER D, GOEKE SC et al.: Dynamic analysis of proviral induction and de novo methylation: implications for a histone deacetylase-independent, methylation density- dependent mechanism of transcriptional repression. Mo/. Cell. Biol. (2000) 20:842–850.
   Web of Science ®Google Scholar
• •Analysis of mechanisms involved in silencing of integrated transgenes.
   Google Scholar
• SMITH KT, SHEPHERD AJ, BOYD JE, LEES GM: Gene delivery systems for use in gene therapy: an overview of quality assurance and safety issues. Gene Ther. (1996) 3:190–200.
   PubMed Web of Science ®Google Scholar
• HUSER A, RUDOLPH M, HOFMANN C et al.: Incorporation of decay-accelerating factor into the baculovirus envelope generates complement-resistant gene transfer vectors. Nat. BiotechnoL (2001) 19: 451–455.
   Google Scholar
• PANDYA S, KLIMATCHEVA E, PLANELLES V: Lentivirus and foamy virus vectors: novel gene therapy tools. E. Opin. Biol Ther. (2001) 1:17–40.
   PubMed Web of Science ®Google Scholar
• KOBINGER GP, WEINER DJ, YU QC, WILSON JM: Filovirus-pseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo. Nat. Biotechnol. (2001) 19:225–230.
   PubMed Web of Science ®Google Scholar
• CONSIGLIO A, QUATTRINI A, MARTINO S et al.: In vivo gene therapy of metachromatic leukodystrophy by lentiviral vectors: correction of neuropathology and protection against learning impairments in affected mice. Nat. Med. (2001) 7:310–316.
   PubMed Web of Science ®Google Scholar
• GUENECHEA G, GAN OI, INAMITSU T et al.: Transduction of human CD34+ CD38- bone marrow and cord blood-derived SCID-repopulating cells with third-generation lentiviral vectors. Mol Ther. (2000) 1: 566–573.
   Google Scholar
• MAY C, RIVELLA S, CALLEGARI J et al.: Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin. Nature (2000)406: 82–86.
   Google Scholar
• •Lentiviral transduction of HSCs.
   Google Scholar
• ZUFFEREY R, DULL T, MANDEL RJ et al.: Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J. Virol. (1998) 72:9873–9880.
   PubMed Web of Science ®Google Scholar
• BROWNING MT, SCHMIDT RD, LEW KA, RIZVI TA: Primate and feline lentivirus vector RNA packaging and propagation by heterologous lentivirus virions. J. Vim/.(2001) 75:5129–5140.
   Web of Science ®Google Scholar
• WILSON JM: Adenoviruses as gene-delivery vehicles. N Engl J. Med. (1996) 334:1185–1187.
   PubMed Web of Science ®Google Scholar
• SILMAN NJ, FOOKS AR: Biophysical targeting of adenovirus vectors for gene therapy. Curr. Opin. Mol Ther. (2000) 2: 524–531.
   Google Scholar
• KOCHANEK S, CLEMENS PR, MITANI K et al.: A new adenoviral vector: Replacement of all viral coding sequences with 2 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase. Proc. Natl. Acad. Sci. USA (1996) 93:5731–5736.
   PubMed Web of Science ®Google Scholar
• •Generation of 'gutless' adenoviral vectors.
   Google Scholar
• BALAGUE C, ZHOU J, DAI Y et al.: Sustained high-level expression of full-length human Factor VIII and restoration of clotting activity in hemophilic mice using a minimal adenovirus vector. Blood (2000) 95:820–828.
   PubMed Web of Science ®Google Scholar
• MAIONE D, ROCCA CD, GIANNETTI P et al.: An improved helper-dependent adenoviral vector allows persistent gene expression after intramuscular delivery and overcomes preexisting immunity to adenovirus. Proc. Natl Acad. Sci. USA (2001) 98:5986–5991.
   PubMed Web of Science ®Google Scholar
• KAFRI T, MORGAN D, KRAHL T et al.: Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: Implications for gene therapy. Proc. Natl Acad. Sci. USA (1998) 95:11377–11382.
   PubMed Web of Science ®Google Scholar
• FALLAUX FJ, BOUT A, VAN DER VELDE I, VAN DEN WOLLENBERG DJ, HEHIR KM: New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Hum. Gene Ther. (1998) 9:1909–1917.
   PubMed Web of Science ®Google Scholar
• ZHOU H, ZHAO T, PASTORE L et al.: A cre-expressing cell line and an el /e2a double-deleted virus for preparation of helper-dependent adenovirus vector. Mol Ther. (2001) 3:613–622.
   PubMed Web of Science ®Google Scholar
• NYBERG-HOFFMAN C, AGUILAR-CORDOVA E: Instability of adenoviral vectors during transport and its implication for clinical studies. Nat. Med. (1999) 5:955–957.
   PubMed Web of Science ®Google Scholar
• STEIN WAERDER DS, CARLSON CA, OTTO DL et al.: Tumor-specific gene expression in hepatic metastases by a replication-activated adenovirus vector. Nat. Med. (2001) 7:240–243.
   PubMed Web of Science ®Google Scholar
• ••Interesting approach to cancer genetherapy.
   Google Scholar
• YOUNG SM Jr., MCCARTY DM, DEGTYAREVA N, SAMULSKI RJ: Roles of adeno-associated virus Rep protein and human chromosome 19 in site-specific recombination. J. Virol. (2000) 74:3953–3966.
   PubMed Web of Science ®Google Scholar
• YAN Z, ZHANG Y, DUAN D, ENGELHARDT JF: Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy. Proc. Natl Acad. Sci. USA (2000) 97:6716–6721.
   PubMed Web of Science ®Google Scholar
• •Generation of high capacity AAV vectors.
   Google Scholar
• SUN L, LI J, MAO X: Overcoming adeno- associated virus vector size limitation through viral DNA heterodimerization. Nat. Med. (2000) 6:599–602.
   PubMed Web of Science ®Google Scholar
• •Generation of high capacity AAV vectors.
   Google Scholar
• NAKAI H, STORM TA, KAY MA: Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectors. Nat. Biotechnol (2000) 18:527–532.
   PubMed Web of Science ®Google Scholar
• •Generation of high capacity AAV vectors.
   Google Scholar
• MAO X. LI J. SAMULSKI RJ: Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol. (1998) 72:2224–2232.
   PubMed Web of Science ®Google Scholar
• ALLEN JM, HALBERT CL, MILLER AD: Improved adeno-associated virus vector production with transfection of a single helper adenovirus gene, E4orf6. Mol Ther. (2000) 1:88–95.
   PubMed Web of Science ®Google Scholar
• HAUSWIRTH WW, LEWIN AS, ZOLOTUKHIN S, MUZYCZKA N: Production and purification of recombinant adeno-associated virus. Methods Enzymol. (2000) 316:743–761.
   PubMed Web of Science ®Google Scholar
• MAO W, CHIRMULE N, BERTA SC, MCCULLOUGH B, GAO G: Gene therapy vectors based on adeno-associated virus Type 1.J. Virol. (1999) 73:3994–4003.
   PubMed Web of Science ®Google Scholar
• LATCHMAN DS, COFFIN RS: Viral vectors for gene therapy in Parkinson's disease. Rev. Neurosci. (2001) 12:69–78.
   PubMed Web of Science ®Google Scholar
• SAMANIEGO LA, NEIDERHISER L, DELUCA NA: Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins. J. Virol. (1998) 72:3307–3320.
   PubMed Web of Science ®Google Scholar
• GOSS JR, MATA M, GOINS WF et al.: Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion. Gene Ther. (2001) 8:551–556.
   PubMed Web of Science ®Google Scholar
• ••Interesting gene therapy approach utilisingintrinsic herpes virus properties.
   Google Scholar
• YEUNG SN, TUFARO F: Replicating herpes simplex virus vectors for cancer gene therapy. Expert Opin. Pharmacother. (2000) 1: 623–631.
   Google Scholar
• STRAYER DS: 5V40-based gene therapyvectors: turning an adversary into a friend. Curr. Opin. Mol Ther. (2000) 2:570–578.
   PubMed Web of Science ®Google Scholar
• MASTRANGELO MJ, EISENLOHR LC, GOMELLA L, LATTIME EC: Poxvirus vectors: orphaned and underappreciated. J. Clin. Invest. (2000) 105:1031–1034.
   PubMed Web of Science ®Google Scholar
• YONEMITSU Y, KITSON C, FERRARI S et al.: Efficient gene transfer to airway epithelium using recombinant Sendai virus. Nat. BiotechnoL (2000) 18:970–973.
   PubMed Web of Science ®Google Scholar
• •Promising results obtained with a new viral vector.
   Google Scholar
• WAHLFORS JJ, ZULLO SA, LOIMAS S et al.: Evaluation of recombinant alphaviruses as vectors in gene therapy. Gene Ther. (2000) 7:472–480.
   PubMed Web of Science ®Google Scholar
• COSTANTINI LC, JACOBY DR, WANG S et al.: Gene transfer to the nigrostriatal system by hybrid herpes simplex virus/ adeno-associated virus amplicon vectors. Hum. Gene Ther. (1999) 10:2481–2494.
   PubMed Web of Science ®Google Scholar
• LIEBER A, STEINWAERDER DS, CARLSON CA, KAY MA: Integrating adenovirus-adeno-associated virus hybrid vectors devoid of all viral genes. J. Virol. (1999) 73:9314–9324.
   PubMed Web of Science ®Google Scholar
• •Generation of a hybrid vector.
   Google Scholar
• FISHER KD, STALLWOOD Y, GREEN NK et al.: Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies. Gene Ther. (2001) 8: 341–348.
   Google Scholar
• CROYLE MA, CHIRMULE N, ZHANG Y, WILSON JM: 'Stealth' adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung. J. Virol. (2001) 75:4792–4801.
   PubMed Web of Science ®Google Scholar
• HART SL: Synthetic vectors for gene therapy. Expert Opin. Ther. Patents (2000) 10:199–208.
   Web of Science ®Google Scholar
• POUTON CW, SEYMOUR LW: Key issues in non-viral gene delivery Adv. Drug Deliv. Rev. (2001) 46:187–203.
   PubMed Web of Science ®Google Scholar
• AIHARA H, MIYAZAKI J: Gene transfer by electroporation in vivo. Nat. Biotech. (1998) 16:867–870.
   PubMed Web of Science ®Google Scholar
• ZANTA MA, BELGUISE-VALLADIER P, BEHR JP: Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc. NatL Acad. Sci. USA (1999) 96:91–96.
   PubMed Web of Science ®Google Scholar
• •Improvement of plasmicl driven expression by tagging with nuclear localisation signal.
   Google Scholar
• HYDE SC, SOUTHERN KW, GILEADI U et al.: Repeat administration of DNA/ liposomes to the nasal epithelium of patients with cystic fibrosis. Gene Ther. (2000) 7:1156–1165.
   PubMed Web of Science ®Google Scholar
• ZHU N, LIGGITT D, LIU Y, DEBS R Systemic gene expression after intravenous DNA delivery into adult mice. Science (1993) 261:209–211.
   PubMed Web of Science ®Google Scholar
• •Distribution of expression following systemic injection of plasmicl vectors.
   Google Scholar
• TSUBONIWA N, MORISHITA R, HIRANO T et al.: Safety evaluation of hemagglutinating virus of Japan - artificial viral envelope liposomes in nonhuman primates. Hum. Gene Ther. (2001) 12:469–487.
   PubMed Web of Science ®Google Scholar
• GAUTAM A, DENSMORE CL, GOLUNSKI E, XU B, WALDREP JC: Transgene expression in mouse airway epithelium by aerosol gene therapy with PEI-DNA complexes. MoL Ther. (2001) 3:551–556.
   PubMed Web of Science ®Google Scholar
• GODBEY WT, WU KK, MIKOS AG: Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. Proc. Natl. Acad Sci. USA (1999) 96:5177–5181.
   PubMed Web of Science ®Google Scholar
• OGRIS M, BRUNNER S, SCHULLER S et al.: PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther. (1999) 6:595–605.
   PubMed Web of Science ®Google Scholar
• WARD CM, READ ML, SEYMOUR LW: Systemic circulation of poly(L-lysine)/DNA vectors is influenced by polycation molecular weight and type of DNA: differential circulation in mice and rats and the implications for human gene therapy. Blood (2001) 97:2221–2229.
   PubMed Web of Science ®Google Scholar
• NORMAND N, VAN LEEUWEN H, O'HARE P: Particle formation by a conserved domain of the herpes simplex virus protein VP22 facilitating protein and nucleic acid delivery. J. Biol. Chem. (2001) 276:15042-MS0.
   Google Scholar
• BONADIO J, SMILEY E, PATIL P, GOLDSTEIN S: Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nat. Med. (1999) 5:753–759.
   PubMed Web of Science ®Google Scholar
• ROY K, MAO HQ, HUANG SK, LEONG KW: Oral gene delivery with chitosan--DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat. Med. (1999) 5:387–391.
   PubMed Web of Science ®Google Scholar
• ••Innovative approach to tolerance inductionvia gene therapy.
   Google Scholar
• WALTHER W, STEIN U, FICHTNER I et al.: Nonviral in vivo gene delivery into tumors using a novel low volume jet-injection technology. Gene Ther. (2001) 8:173–180.
   PubMed Web of Science ®Google Scholar
• BELLDEGRUN A, TSO CL, ZISMAN A et al.: Interleukin 2 gene therapy for prostate cancer: Phase I clinical trial and basic biology. Hum. Gene Ther. (2001) 12:883–892.
   PubMed Web of Science ®Google Scholar
• BAUMGARTNER I, PIECZEK A, MANOR 0 et al.: Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation (1998) 97:1114–1123.
   PubMed Web of Science ®Google Scholar
• BROWN WR, MEE PJ, HONG SHEN M. Artificial chromosomes: ideal vectors?Trends BiotechnoL (2000) 18:218–223.
   PubMed Web of Science ®Google Scholar
• CSONKA E, CSERPAN I, FODOR K et al.: Novel generation of human satellite DNA-based artificial chromosomes in mammalian cells. J. Cell. Sci. (2000) 113:3207–3216.
   PubMed Web of Science ®Google Scholar
• GUIDUCCI C, ASCENZIONI F, AURICHE C et al.: Use of a human minichromosome as a cloning and expression vector for mammalian cells. Hum. MoL Genet. (1999) 8:1417–1424.
   PubMed Web of Science ®Google Scholar
• WADE-MARTINS R, WHITE RE, KIMURA H et al.: Stable correction of a genetic deficiency in human cells by an episome carrying a 115 kb genomic transgene. Nat. BiotechnoL (2000) 18:1311–1314.
   PubMed Web of Science ®Google Scholar
• •An interesting example of an episomal vector.
   Google Scholar
• LEE CG, VIEIRA WD, PASTAN I, GOTTESMAN MM: An episomally maintained mdr1 gene for gene therapy. Hum. Gene Ther. (2001) 12:945–953.
   PubMed Web of Science ®Google Scholar
• JOOSS K, YANG Y, FISHER KJ, WILSON JM: Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers. J. Ord (1998) 72:4212–4223.
   Google Scholar
• LEE RJ, SPRINGER ML, BLANCO- BOSE WE et al.: VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation (2000) 102:898–901.
   PubMed Web of Science ®Google Scholar
• •Overexpression of transgene resulting in angioma formation.
   Google Scholar
• ZHU X, HADHAZY M, GROH ME et al.: Overexpression of {gamma}-sarcoglycan induces severe muscular dystrophy: Implications for the regulation of sarcoglycan assembly./ BioL Chem. (2001) [e-pub ahead of print]
   Google Scholar
• POLLOCK R, RIVERA VM. Regulation of gene expression with synthetic dimerizers. Methods EnzymoL (1999) 306:263–281.
   PubMed Web of Science ®Google Scholar
• GOSSEN M, FREUNDLIEB S, BENDER G et al.: Transcriptional activation by tetracyclines in mammalian cells. Science (1995) 268:1766–1769.
   PubMed Web of Science ®Google Scholar
• WANG Y, DEMAYO FJ, TSAI SY, O'MALLEY BW: Ligand-inducible and liver-specific target gene expression in transgenic mice. Nat. BiotechnoL (1997) 15:239–243.
   PubMed Web of Science ®Google Scholar
• NO D, YAO TP, EVANS RM. Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc. Natl. Acad Sci. USA (1996) 93: 3346–3351.
   Google Scholar
• BURCIN MM, SCHIEDNER G, KOCHANEK S, TSAI SY, O'MALLEY BW: Adenovirus-mediated regulable target gene expression in vivo. Proc. NatL Acad. Sci. USA (1999) 96:355–360.
   PubMed Web of Science ®Google Scholar
• •Example of a vector allowing tissue-specific and reversible regulation of expression levels.
   Google Scholar
• KOWOLIK CM, HU J, YEE JK: Locus control region of the human cd2 gene in a lentivirus vector confers position-independent transgene expression. J. Virol. (2001) 75:4641–4648.
   PubMed Web of Science ®Google Scholar
• LEE HC, KIM SJ, KIM KS, SHIN HC, YOON JW: Remission in models of Type 1 diabetes by gene therapy using a single-chain insulin analogue. Nature (2000) 408:483–488.
   PubMed Web of Science ®Google Scholar
• •Example of efficient physiological regulation of transgene expression. accelerate autoimmune responses. Gene Ther. (2001) 8:1354–1356.
   Google Scholar
• SCHIEDNER G, MORRAL N, PARKS RJ!et al.: Genomic DNA transfer with a high capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat. Genet. (1998) 18:180–183.
   PubMed Web of Science ®Google Scholar
• FIELDS PA, ARMSTRONG E, HAGSTROM JN et al.: Intravenous administration of an E1/E3-deleted adenoviral vector induces tolerance to Factor IX in C57BL/6 mice. Gene Ther. (2001) 8:354–361.
   PubMed Web of Science ®Google Scholar
• PRASAD SA, NORBURY CC, CHEN W, BENNINK JR, YEWDELL JW. Cutting edge: recombinant adenoviruses induce CD8 T cell responses to an inserted protein whose expression is limited to nonimmune cells. J. immune/. (2001) 166:4809–4812.
   PubMed Web of Science ®Google Scholar
• DEWEY RA, MORRISSEY G, COWSILL CM et al.: Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: implications for clinical trials. Nat. Med. (1999) 5:1256–1263.
   PubMed Web of Science ®Google Scholar
• Cl-JAN SY, LI K, PICCOTTI JR et al.: Tissue-specific consequences of the anti-adenoviral immune response: implications for cardiac transplants. Nat. Med. (1999) 5:1143–1149.
   PubMed Web of Science ®Google Scholar
• CHIRMULE N, MAO W, TRUNEH A et al.: Humoral immunity to adeno-associated virus Type 2 vectors allowing administration to murine and nonhuman primate muscle. J. Vim/. (2000) 74:2420–2425.
   Web of Science ®Google Scholar
• SATO Y, ROMAN M, TIGHE H et al.: Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science (1996) 273:352–354.
   PubMed Web of Science ®Google Scholar
• ••Paper describing characterisation of SIS ina number of genes present in commonly used plasmids.
   Google Scholar
• MACCOLL G, BUNN C, GOLDSPINK G, BOULOUX P, GORECKI DC:
   Google Scholar
• TRIPATHY SK, BLACK HB, responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat. Med. (1996) 2: 545–550.
   Google Scholar
• RIDDELL SR, ELLIOTT M,LEWINSOHN DA et al.: T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nat. Med. (1996) 2:216-223.•Transgene immunogenicity in severely immunocompromised individuals.
   Google Scholar
• • Transgene immunogenicity in severely immunocompromised individuals.
   Google Scholar
• BITTNER RE, SHORNY S, STREUBEL B et al.: Serum antibodies to the deleted dystrophin sequence after cardiac transplantation in a patient with Becker’s muscular dystrophy. N. Engl. J. Med. (1995) 333:732–733
   PubMedGoogle Scholar
• Recent patents in gene therapy. Nat. Biotechnol. (2001) 19:483.
   Google Scholar
• MARSHALL E: Gene therapy's web of corporate connections. Science (2000) 288:954–955.
   PubMedGoogle Scholar
• JUNG SC, HAN IP, LIMAYE A et al.: Adeno-associated viral vector-mediated gene transfer results in long-term enzymatic and functional correction in multiple organs of Fabty mice. Proc. Natl. Acad Sci. USA (2001) 98:2676–2681.
   PubMed Web of Science ®Google Scholar
• GREELISH JP, SU LT, LANKFORD EB et al.: Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector. Nat. Med. (1999) 5:439–443.
   PubMed Web of Science ®Google Scholar
• ACLAND GM, AGUIRRE GD, RAY J et al.: Gene therapy restores vision in a canine model of childhood blindness. Nat. Genet. (2001) 28:92-95. DURING MJ, XU R, YOUNG D et al.: Peroral gene therapy of lactose intolerance using an adeno-associated virus vector. Nat. Med. (1998) 4:1131-1135. MCINERNEY JM, NAWROCKI JR, LOWREY CH: Long-term silencing of retroviral vectors is resistant to reversal by trichostatin A and 5-azacytidine. Gene Ther. (2000)7:653-663. LAGASSE E, CONNORS H, AL-DHALIMY M et al.: Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat. Med. (2000) 6:1229-1234. TORRENTE Y, TREMBLAY JP, PISATI F et al.: Intra arterial injection of muscle-derived CD34(+)Sca-1(+) stem cells restores dystrophin in MDX mice. J. Cell. Biol. (2001) 152:335–348.
   PubMed Web of Science ®Google Scholar
• DURING MJ, XU R, YOUNG D et al.: Peroral gene therapy of lactose intolerance using an adeno-associated virus vector. Nat. Med. (1998) 4:1131-1135.105. MEZEY E, CHANDROSS KJ, HARTA G, MAKI RA, MCKERCHER SR Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow Science (2000) 290: 1779–1782.
   Google Scholar
• MCINERNEY JM, NAWROCKI JR, LOWREY CH: Long-term silencing of retroviral vectors is resistant to reversal by trichostatin A and 5-azacytidine. Gene Ther.(2000) 7:653–663.
   PubMed Web of Science ®Google Scholar
• LAGASSE E, CONNORS H, ALDHALIMY M et al.: Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat. Med. (2000) 6:1229–1234.
   PubMed Web of Science ®Google Scholar
• TORRENTE Y, TREMBLAY JP, PISATI F et al.: Intra arterial injection of musclederived CD34(+)Sca-1(+) stem cells restores dystrophin in MDX mice. J. Cell. Biol.(2001) 152:335–348.
   Google Scholar
• MEZEY E, CHANDROSS KJ, HARTA G,MAKI RA, MCKERCHER SR: Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science (2000) 290:1779–1782.
   PubMed Web of Science ®Google Scholar
• ••Transplanted adult bone marrow cellsmigrated into the brain and differentiated into cells that expressed neurone-specific antigens.
   Google Scholar
• KRAUSE DS, THEISE ND, COLLECTOR MI et al.: Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell (2001) 105:369–377.
   PubMed Web of Science ®Google Scholar
• ••Identification and isolation ofhaematopoietic stem cells.
   Google Scholar